A recent study by researchers from the NUS Yong Loo Lin School of Medicine has been claiming that the antibody with the ability to kill the dengue virus has been found in humans.

The team funded for the study by the Singapore National Research Foundation has reached the breakthrough in collaboration with the Defence Medical & Environmental Research Institute at DSO National Laboratories and Duke-NUS Graduate Medical School.

Since the world is at a risk of facing 50-100 million dengue infections each year as per the World Health Organization, the team was focused at finding a cure for the same. It has been found that at present, no treatment vaccine is available for the deadly infection.

However, some cases are prevented with the help of vector control, but the number of targets is not diminishing anyhow.

The team included people who were survivors of the virus and studied a group of cell lines for two years. It helped it in discovering that a recombinant antibody combining with a part of the virus averted it from attacking further.

Also, the virus was ultimately killed by the antibody at a very high speed. "We are very encouraged by this breakthrough. This represents the best candidate therapy that currently exists for dengue", said Associate Professor Paul Macary.